06/17/2026
The CNS Clinical Trials Event at the Center for Advanced Human Brain Imaging Research (CAHBIR) within the Rutgers Brain Health Institute concluded on June 11, gathering over 30 attendees from leading pharma companies and Rutgers University leaders, investigators, and clinical research teams.
The event highlighted advancing CNS research through academic–industry collaboration, showcasing Rutgers’ infrastructure for industry-sponsored CNS clinical trials, patient recruitment, regulatory support, advanced imaging at CAHBIR, and opportunities to connect with Rutgers and RWJBarnabas Health experts.
Grateful for such meaningful conversations to accelerate innovation in CNS therapeutics! Thank you to all attendees from Merck, Novartis, Sanofi, Eli Lilly and Company, Eisai Inc., GE Healthcare, Tris Pharma, Inc., Zena Therapeutics, and C2N Diagnostics for joining us!
Learn more about CAHBIR’s services in the brochure:https://brainhealthinstitute.rutgers.edu/wp-content/uploads/2026/04/CAHBIR-Capabilities-Brochure_2026.pdf